3/10
03:38 pm
ebs
How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset [Yahoo! Finance]
Low
Report
How The Investment Narrative For Emergent BioSolutions (EBS) Is Shifting After The $12 Target Reset [Yahoo! Finance]
3/10
05:52 am
ebs
BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
BioThrax (Emergent BioSolutions) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/9
11:29 am
ebs
Acam2000 Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
Low
Report
Acam2000 Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F [Yahoo! Finance]
3/9
08:03 am
ebs
Emergent Biosolutions (EBS) had its price target lowered by HC Wainwright from $15.00 to $12.00. They now have a "buy" rating on the stock.
Low
Report
Emergent Biosolutions (EBS) had its price target lowered by HC Wainwright from $15.00 to $12.00. They now have a "buy" rating on the stock.
3/8
01:31 am
ebs
Low
Report
3/3
06:12 pm
ebs
Emergent Biosolutions (EBS) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
Low
Report
Emergent Biosolutions (EBS) was downgraded by
Weiss Ratings from "hold (c-)" to "sell (d+)".
3/3
08:13 am
ebs
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors [Yahoo! Finance]
Low
Report
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors [Yahoo! Finance]
3/3
08:00 am
ebs
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
Low
Report
Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
2/28
01:18 am
ebs
Emergent Biosolutions Q4 Earnings Call Highlights [Yahoo! Finance]
Medium
Report
Emergent Biosolutions Q4 Earnings Call Highlights [Yahoo! Finance]
2/27
11:45 pm
ebs
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... [Yahoo! Finance]
Medium
Report
Emergent BioSolutions Inc (EBS) Q4 2025 Earnings Call Highlights: Strategic Gains Amid Revenue ... [Yahoo! Finance]
2/27
12:02 am
ebs
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances [Seeking Alpha]
Medium
Report
Emergent BioSolutions outlines $720M–$760M 2026 revenue target as transformation plan advances [Seeking Alpha]
2/26
04:22 pm
ebs
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program [Yahoo! Finance]
High
Report
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program [Yahoo! Finance]
2/26
04:05 pm
ebs
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
High
Report
Emergent BioSolutions Reports Fourth Quarter and Full Year 2025 Financial Results
2/26
04:01 pm
ebs
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
High
Report
Emergent BioSolutions Announces New $50 Million Stock Repurchase Program
2/26
04:01 pm
ebs
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
High
Report
Emergent BioSolutions Announces Approximately $140 Million in Contract Awards with the Government of Canada, Strengthening Canada’s Leadership in Health Preparedness
2/12
06:00 pm
ebs
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
Low
Report
Emergent BioSolutions Receives U.S. FDA Approval of Supplemental New Drug Application (sNDA) for NARCAN® Nasal Spray Multipacks
2/12
09:16 am
ebs
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
Low
Report
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026 [Yahoo! Finance]
2/12
09:02 am
ebs
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
Low
Report
Emergent BioSolutions to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026
1/16
10:57 am
ebs
?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]
Low
Report
?Emergent BioSolutions (EBS) Receives a New Order from US Department of War [Yahoo! Finance]
1/15
06:04 pm
ebs
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]
Low
Report
New York Sues Former C.E.O. of Covid Vaccine Maker Over Insider Trading [The New York Times]
1/15
05:52 pm
ebs
Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]
Low
Report
Former biotech CEO sued over COVID vaccine alleged insider trading [Yahoo! Finance]
1/14
08:00 am
ebs
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
Low
Report
Emergent BioSolutions Receives U.S. FDA Approval on Supplemental New Drug Application for NARCAN® Nasal Spray to be Packaged in a New Carrying Case, Making Life-Saving Naloxone More Accessible for Everyday Preparedness
1/12
07:30 am
ebs
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
Medium
Report
Emergent BioSolutions Announces $100 Million Paydown of Term Loan Principal, a Significant Step Achieved Toward its Multi-year Transformation
1/8
04:30 pm
ebs
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
Low
Report
Emergent BioSolutions Receives Delivery Order up to $21.5 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of War in 2026
1/8
08:00 am
ebs
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa
Medium
Report
Emergent BioSolutions and PANTHER Announce Agreement to Support the Continuation of the Africa CDC-led MpOx Study in Africa